Grand Junction, CO, United States of America

Patrick Iversen

This inventor holds 2 USPTO granted patents. Top assignees: Immunesure LLC, Oncocine, LLC. Active years: 2025-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick Iversen

Introduction

Patrick Iversen is a notable inventor based in Grand Junction, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic vaccines. With a total of 2 patents, Iversen's work focuses on enhancing immune responses to various medical treatments.

Latest Patents

Iversen's latest patents include groundbreaking innovations such as "RNA-Based Adjuvant to Enhance the Immune Response to Vaccines and Therapeutics" and "Therapeutic mRNA Vaccine for Malignancies." These patents reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Iversen has worked with several companies, including Oncocine, LLC and Immunesure LLC. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to important research initiatives.

Collaborations

Iversen has collaborated with notable professionals such as Nickolas Kipshidze and Nodar Kipshidze. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Patrick Iversen's innovative contributions to biotechnology and his dedication to improving therapeutic approaches make him a significant figure in the field. His patents and collaborations highlight the importance of continued research and development in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…